Evidence method
Level · gp.fundamentals.capex_revenue_ratio
18.59% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CYRX · Jun 30, 2026
Cryoport, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-092107General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.31% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
7.74% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
43.92% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
46.61% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-20.50% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.91% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.90% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 20.88%
- Current
- 18.59%
- Delta
- -2.29%
- Previous
- 7.81%
- Current
- 2.31%
- Delta
- -5.50%
- Previous
- 16.47%
- Current
- 7.74%
- Delta
- -8.73%
- Previous
- 45.50%
- Current
- 43.92%
- Delta
- -1.59%
- Previous
- 45.84%
- Current
- 46.61%
- Delta
- 0.76%
- Previous
- -20.11%
- Current
- -20.50%
- Delta
- -0.39%
- Previous
- 8.17%
- Current
- 9.91%
- Delta
- 1.73%
- Previous
- 5.01%
- Current
- 4.90%
- Delta
- -0.11%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Transitioned To · CYRX Fundamental State →Transitioned To · CYRX CAPEX_INTENSITY_DECREASED →Transitioned To · CYRX CASH_GENERATION_DECREASED →Transitioned To · CYRX GROWTH_DECREASED →Transitioned To · CYRX INVENTORY_PRESSURE_DECREASED →Transitioned To · CYRX MARGIN_INCREASED →Transitioned To · CYRX PROFITABILITY_DECREASED →Transitioned To · CYRX R_AND_D_INTENSITY_INCREASED →Transitioned To · CYRX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.